MS Speaks

Multiple Sclerosis => TREATMENTS => GILENYA (fingolimod, FTY720) => Topic started by: agate on March 16, 2018, 11:51:28 am

Title: (Abst.) Fingolimod effect on gray matter, thalamus and white matter in PwMS
Post by: agate on March 16, 2018, 11:51:28 am

The researchers conclude that:

Quote

Fingolimod significantly reduced dGM volume loss (including thalamus) vs placebo in patients with RRMS. Reducing dGM and thalamic volume loss might improve long-term outcome.

From PubMed, March 16, 2018:https://www.ncbi.nlm.nih.gov/pubmed/29540589